INVA vs PAHC: stock comparison and AI forecast
Innoviva, Inc. (INVA) and Phibro Animal Health Corp (PAHC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
INVA Innoviva, Inc.
- Market Cap
- $1.52B
- P/E Ratio
- 5.8x
- Size
- small-cap
- AI Forecast
PAHC Phibro Animal Health Corp
- Market Cap
- $1.57B
- P/E Ratio
- 15.9x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- INVA and PAHC have similar market capitalizations ($1.52B and $1.57B).
- INVA trades at 5.8 times trailing earnings, PAHC at 15.9 times.
- PAHC yields 1.24% in dividends; INVA pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | INVA | PAHC |
|---|---|---|
| Market Cap | $1.52B | $1.57B |
| P/E Ratio | 5.82x | 15.94x |
| P/B Ratio | 1.23x | – |
| Dividend Yield | – | 1.24% |
| EPS | $3.61 | $2.43 |
| Book Value/Share | $17.07 | – |
| Revenue/Share | $0.42 | $37.39 |
| FCF/Share | $2.62 | $0.24 |
Profitability & Margins
| Metric | INVA | PAHC |
|---|---|---|
| ROE | 29.0% | – |
| ROA | 21.0% | – |
| ROIC | 9.8% | – |
| Gross Margin | – | 33.8% |
| Operating Margin | 538.2% | 28.1% |
| Net Margin | 1182.5% | – |
| EBT Margin | 1388.3% | 19.8% |
| Tax Rate | 14.8% | 27.4% |
Financial Health
| Metric | INVA | PAHC |
|---|---|---|
| Current Ratio | 16.01x | – |
| Quick Ratio | 15.18x | – |
| D/E Ratio | 0.38x | – |
| Financial Leverage | 1.38x | – |
| Interest Coverage | 9.3x | 1.1x |
| Working Capital | $706M | – |
Cash Flow
| Metric | INVA | PAHC |
|---|---|---|
| Operating Cash Flow | $191M | $69M |
| Free Cash Flow | $189M | $10M |
| Capital Spending | -$2M | -$59M |
| OCF Growth YoY | -4.5% | -13.9% |
| FCF Growth YoY | – | -71.2% |
| FCF/Sales | 627.1% | 0.7% |
| CapEx/Sales | 6.8% | 3.9% |
Operational Efficiency
| Metric | INVA | PAHC |
|---|---|---|
| Asset Turnover | 0.02x | – |
| Receivables Turnover | 0.6x | – |
| Fixed Assets Turnover | 14.2x | – |
| Days Sales Outstanding | 614 days | – |
Income Statement
| Metric | INVA | PAHC |
|---|---|---|
| Total Revenue | $30M | $1.52B |
| Operating Income | $163M | $194M |
| Net Income | $357M | – |
| R&D Expense | $29M | – |
| SG&A Expense | $126M | $318M |
| Cost of Goods Sold | – | $1.01B |
Dividend & Shareholder Information
| Metric | INVA | PAHC |
|---|---|---|
| Dividends Per Share | – | $0.48 |
| Payout Ratio | – | 19.8% |
| Shares Outstanding | 72M | 41M |
| Net Income Growth | 824.3% | – |
| EPS Growth | 114.9% | 104.2% |
INVA vs PAHC: stock comparison and AI forecast
Which is bigger, INVA or PAHC?
INVA and PAHC have similar market capitalizations ($1.52B and $1.57B).
Which is cheaper on earnings, INVA or PAHC?
INVA trades at 5.8 times trailing earnings, PAHC at 15.9 times.
Which one does Intratio's AI model rank higher, INVA or PAHC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.